AIDS.GOV | SERVICE LOCATOR | SEARCH

BLOG.AIDS.GOV

MENU

NIH

Measuring Stigma: Where Do We Go From Here?

Laura Nyblade - stigma graph - blog image

Prejudices and negative attitudes directed towards people living with HIV have very real consequences: Stigma discourages people from getting tested for HIV, sharing their HIV positive status with loved ones, and seeking care and sticking to treatment. Yet in the early years of the HIV epidemic, it was thought that the stigma surrounding HIV was…

White House Meeting on HIV Stigma Examines Interventions, Measures, Actions

White House Meeting on HIV Stigma: Research for a Robust Response

Summary: On March 3, ONAP and NIH co-hosted the White House Meeting on HIV Stigma: Research for a Robust Response. As we approach the 35th anniversary of the first case reports of what would later come to be known as HIV/AIDS, we can rightfully celebrate that we now have an array of effective tools to prevent…

Liver Cancer Death Rate Increasing Faster Than All Other Cancers; Implementation of Viral Hepatitis Action Plan Urgently Needed

cdc viral hep report - crop version

On March 9th, the American Cancer Society, Centers for Disease Control and Prevention (CDC), National Cancer Institute, and the North American Association of Central Cancer Registries released their Annual Report to the Nation on the Status of Cancer  , revealing that the rate of new cases of liver cancer is rapidly increasing and the death rate…

Research Update: NIH’s Dr. Dieffenbach on CROI 2016 (Video)

drcarl

As the 2016 Conference on Retroviruses and Opportunistic Infections (CROI)  came to a close in Boston on February 25, we spoke with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), about some of the highlights of the HIV research presented there. He notes that there…

Vaginal Ring & PrEP Updates from CROI with NIH’s Dr. Carl Dieffenbach (Video)

DrDieffenbach

New scientific findings to inform HIV prevention efforts were among the key highlights shared at CROI yesterday, according to Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID). After another day full of presentations on the latest in HIV science at the 2016 Conference on…

NIH-Funded Study Finds Critical Population Adheres to PrEP with Coordinated Care

blackmsm

New findings suggest that black men who have sex with men (BMSM) with access to a novel coordinated care program can adhere to pre-exposure prophylaxis (PrEP), a medication regimen that helps prevent HIV infection in uninfected individuals. Researchers reported their results today at a press conference at the Conference on Retroviruses and Opportunistic Infections (CROI)…

NIH’s Dr. Carl Dieffenbach Shares Highlights from Start of CROI 2016 (Video)

croiday1

After the first full day of sessions at the 2016 Conference on Retroviruses and Opportunistic Infections (CROI) in Boston yesterday, February 23, we caught up with Dr. Carl Dieffenbach, Director of the Division of AIDS at NIH’s National Institute of Allergy and Infectious Diseases (NIAID), to get his take on some of the key highlights of…

NIH-Funded Study Finds Effect of PrEP on Bone Density is Reversible

nih logo

The slight loss in bone mineral density associated with HIV pre-exposure prophylaxis (PrEP) antiretroviral use is reversible in young adult patients who stop taking the drugs, according to findings presented by researchers today at the 23rd Conference on Retroviruses and Opportunistic Infections (CROI) in Boston. PrEP is an HIV prevention strategy in which at-risk HIV-negative…